Enliven Therapeutics ELVN Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Enliven Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enliven Therapeutics's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enliven Therapeutics's price / book?
- Enliven Therapeutics (ELVN) reported price / book of 5.2× in Q1 2026.
- How has Enliven Therapeutics's price / book changed year-over-year?
- Enliven Therapeutics's price / book increased by 54.6% year-over-year, from 3.3× to 5.2×.
- What is the long-term trend for Enliven Therapeutics's price / book?
- Over 3 years (2020 to 2025), Enliven Therapeutics's price / book has grown at a -24.3% compound annual growth rate (CAGR), from 4.6× to 2×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.